HAVCR2 and glioblastoma: Very little is known regarding the transcriptional and epigenetic regulation of TIM-3 in the glioblastoma setting, although we have shown that T and NK cells from glioblastoma patients display reduced BAT3 expression, potentially allowing for enhanced TIM-3 expression and function [35].